This company listing is no longer active
Top Glove Corporation Bhd Valuation
Is 5OU undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 5OU when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 5OU (€0.98) is trading below our estimate of fair value (€2.11)
Significantly Below Fair Value: 5OU is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 5OU?
Key metric: As 5OU is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is 5OU's PE Ratio? | |
|---|---|
| PE Ratio | 10.6x |
| Earnings | RM 735.96m |
| Market Cap | RM 7.81b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1.1x |
| Enterprise Value/EBITDA | 6x |
| PEG Ratio | 0.5x |
Price to Earnings Ratio vs Peers
How does 5OU's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 24.4x | ||
PHH2 Paul Hartmann | 12x | n/a | €710.3m |
EUZ Eckert & Ziegler | 21.3x | 4.0% | €802.1m |
SBS Stratec | 35.3x | 25.4% | €353.7m |
COP CompuGroup Medical SE KGaA | 29x | 32.9% | €729.5m |
5OU Top Glove Corporation Bhd | 10.6x | 20.7% | €7.8b |
Price-To-Earnings vs Peers: 5OU is good value based on its Price-To-Earnings Ratio (10.6x) compared to the peer average (25.6x).
Price to Earnings Ratio vs Industry
How does 5OU's PE Ratio compare vs other companies in the European Medical Equipment Industry?
| 3 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 3 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: 5OU is good value based on its Price-To-Earnings Ratio (10.6x) compared to the German Medical Equipment industry average (27.5x)
Price to Earnings Ratio vs Fair Ratio
What is 5OU's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 10.6x |
| Fair PE Ratio | 30.2x |
Price-To-Earnings vs Fair Ratio: 5OU is good value based on its Price-To-Earnings Ratio (10.6x) compared to the estimated Fair Price-To-Earnings Ratio (30.2x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Price is less than 20% discount to the current share price.
Discover undervalued companies
CVS Health
US$69.3b
Provides health solutions in the United States.
CVS
US$50.67
7D
-4.0%
1Y
-19.2%
Fagron
€1.4b
A pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, and patients worldwide.
4A5
€18.54
7D
-1.2%
1Y
9.3%
Shandong Weigao Group Medical Polymer
HK$20.4b
Engages in the research and development, production, wholesale, and sale of medical devices in the People’s Republic of China.
UK2
HK$0.53
7D
-9.5%
1Y
-41.3%